Literature DB >> 24326250

Innate antiviral immune signaling, viral evasion and modulation by HIV-1.

Arjun Rustagi1, Michael Gale2.   

Abstract

The intracellular innate antiviral response in human cells is an essential component of immunity against virus infection. As obligate intracellular parasites, all viruses must evade the actions of the host cell's innate immune response in order to replicate and persist. Innate immunity is induced when pathogen recognition receptors of the host cell sense viral products including nucleic acid as "non-self". This process induces downstream signaling through adaptor proteins to activate latent transcription factors that drive the expression of genes encoding antiviral and immune modulatory effector proteins that restrict virus replication and regulate adaptive immunity. The interferon regulatory factors (IRFs) are transcription factors that play major roles in innate immunity. In particular, IRF3 is activated in response to infection by a range of viruses including RNA viruses, DNA viruses and retroviruses. Among these viruses, human immunodeficiency virus type 1 (HIV-1) remains a major global health problem mediating chronic infection in millions of people wherein recent studies show that viral persistence is linked with the ability of the virus to dysregulate and evade the innate immune response. In this review, we discuss viral pathogen sensing, innate immune signaling pathways and effectors that respond to viral infection, the role of IRF3 in these processes and how it is regulated by pathogenic viruses. We present a contemporary overview of the interplay between HIV-1 and innate immunity, with a focus on understanding how innate immune control impacts infection outcome and disease.
Copyright © 2013. Published by Elsevier Ltd.

Entities:  

Keywords:  HIV; ISG; innate immunity; interferon; virus

Mesh:

Substances:

Year:  2013        PMID: 24326250      PMCID: PMC7425209          DOI: 10.1016/j.jmb.2013.12.003

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  205 in total

1.  Crystal structure of an IRF-DNA complex reveals novel DNA recognition and cooperative binding to a tandem repeat of core sequences.

Authors:  Y Fujii; T Shimizu; M Kusumoto; Y Kyogoku; T Taniguchi; T Hakoshima
Journal:  EMBO J       Date:  1999-09-15       Impact factor: 11.598

2.  Triggering the interferon antiviral response through an IKK-related pathway.

Authors:  Sonia Sharma; Benjamin R tenOever; Nathalie Grandvaux; Guo-Ping Zhou; Rongtuan Lin; John Hiscott
Journal:  Science       Date:  2003-04-17       Impact factor: 47.728

3.  Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated.

Authors:  H Harada; K Willison; J Sakakibara; M Miyamoto; T Fujita; T Taniguchi
Journal:  Cell       Date:  1990-10-19       Impact factor: 41.582

Review 4.  IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.

Authors:  Kenya Honda; Tadatsugu Taniguchi
Journal:  Nat Rev Immunol       Date:  2006-09       Impact factor: 53.106

5.  Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300.

Authors:  M Yoneyama; W Suhara; Y Fukuhara; M Fukuda; E Nishida; T Fujita
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

6.  SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardi-goutières syndrome-associated mutations.

Authors:  Adriana Goncalves; Evren Karayel; Gillian I Rice; Keiryn L Bennett; Yanick J Crow; Giulio Superti-Furga; Tilmann Bürckstümmer
Journal:  Hum Mutat       Date:  2012-04-16       Impact factor: 4.878

7.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

8.  The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.

Authors:  Nanette Van Damme; Daniel Goff; Chris Katsura; Rebecca L Jorgenson; Richard Mitchell; Marc C Johnson; Edward B Stephens; John Guatelli
Journal:  Cell Host Microbe       Date:  2008-03-13       Impact factor: 21.023

9.  The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation.

Authors:  Tommy E White; Alberto Brandariz-Nuñez; Jose Carlos Valle-Casuso; Sarah Amie; Laura Anh Nguyen; Baek Kim; Marina Tuzova; Felipe Diaz-Griffero
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

10.  A diverse range of gene products are effectors of the type I interferon antiviral response.

Authors:  John W Schoggins; Sam J Wilson; Maryline Panis; Mary Y Murphy; Christopher T Jones; Paul Bieniasz; Charles M Rice
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

View more
  32 in total

Review 1.  Innate immunity against HIV-1 infection.

Authors:  Marcus Altfeld; Michael Gale
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

Review 2.  Type I interferon signaling, regulation and gene stimulation in chronic virus infection.

Authors:  Sabelo Lukhele; Giselle M Boukhaled; David G Brooks
Journal:  Semin Immunol       Date:  2019-05-30       Impact factor: 11.130

Review 3.  HIV-1 Infection and Type 1 Interferon: Navigating Through Uncertain Waters.

Authors:  Sho Sugawara; David L Thomas; Ashwin Balagopal
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-15       Impact factor: 2.205

4.  Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.

Authors:  Christine Vazquez; Chin Yee Tan; Stacy M Horner
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

Review 5.  Adenosine signaling and adenosine deaminase regulation of immune responses: impact on the immunopathogenesis of HIV infection.

Authors:  Daniela F Passos; Viviane M Bernardes; Jean L G da Silva; Maria R C Schetinger; Daniela Bitencourt Rosa Leal
Journal:  Purinergic Signal       Date:  2018-08-10       Impact factor: 3.765

6.  Mechanism of Interferon-Stimulated Gene Induction in HIV-1-Infected Macrophages.

Authors:  Najla Nasr; Abdullateef A Alshehri; Thomas K Wright; Maryam Shahid; Bonnie M Heiner; Andrew N Harman; Rachel A Botting; Karla J Helbig; Michael R Beard; Kazuo Suzuki; Anthony D Kelleher; Paul Hertzog; Anthony L Cunningham
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

7.  Large-Scale Arrayed Analysis of Protein Degradation Reveals Cellular Targets for HIV-1 Vpu.

Authors:  Prashant Jain; Guney Boso; Simon Langer; Stephen Soonthornvacharin; Paul D De Jesus; Quy Nguyen; Kevin C Olivieri; Alex J Portillo; Sunnie M Yoh; Lars Pache; Sumit K Chanda
Journal:  Cell Rep       Date:  2018-02-27       Impact factor: 9.423

8.  Retroviral vectors elevate coexpressed protein levels in trans through cap-dependent translation.

Authors:  Yongqiang Gou; Hyewon Byun; Adam E Zook; Gurvani B Singh; Andrea K Nash; Mary M Lozano; Jaquelin P Dudley
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-03       Impact factor: 11.205

9.  Antiviral innate immunity: editorial overview.

Authors:  Eric O Freed; Michael Gale
Journal:  J Mol Biol       Date:  2014-01-22       Impact factor: 5.469

Review 10.  Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis.

Authors:  Yun Zhou; Ying Zhang; Jonathan P Moorman; Zhi Q Yao; Zhan S Jia
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.